期刊文献+

p^(53)在甲状腺肿瘤中的表达及临床意义 被引量:1

The Expression and Significance of P^(53) in Thyroid Tumor
下载PDF
导出
摘要 目的 :探讨 p5 3在甲状腺肿瘤中的表达意义。 方法 :用免疫组化SP法 ,检测 30例甲状腺良性病变、10 0例甲状腺癌中 p5 3的表达。结果 :p5 3在正常甲状腺组织呈阴性表达 ,在甲状腺腺瘤、结节性甲状腺肿、甲状腺乳头状癌、滤泡癌、未分化癌表达阳性率分别为 13.3%、13.3%、36 .4 %、4 2 .9%、4 6 .2 % ,与组织学类型密切相关 (P <0 .0 0 1) ,其中良恶性病变之间差异有显著性 (P <0 .0 5 )。结论 :p5 3是鉴别甲状腺良恶性肿瘤及判断其生物学行为的重要指标。 Objective: To study the significance of the expression of p53 in thyroid carcinoma.Method: Immunohistochemistry was used to detect the expression of p53 in 10 normal thyroid tissues, 30 thyroid benigh disease and 100 thyroid carcinoma. Result: No positive expression of p53 was found in normal thyroid tissues. The positite rate of p53 in thyroid adenoma, nodular goitre, papillary thyroid carcinoma, follicular thyroid carcinoma and undefferentediated carcinoma was 13.3%、13.3%、36.4%、42.9%、46.2% respectively. The expression of p53 was significantly correlated with the various pathologic types of them (P<0.001). Significantly differences of p53 expression can be seen between thyroid benigh and maligant tumor (P<0.05). Conclusion: p53 expression can be important factors for identifying the benigeh and maligant tumor and their biological behaviors.
出处 《河北医学》 CAS 2005年第1期24-26,共3页 Hebei Medicine
关键词 甲状腺肿瘤 P53 免疫组织化学 Thyroid tumor p53 protein Immunohistochemistry
  • 相关文献

参考文献3

二级参考文献5

  • 1Zou M,Br J Carcer,1993年,68卷,2期,385页
  • 2Zou M,J Clin Endocrinol Metab,1993年,77卷,4期,1054页
  • 3Luo W,Thyroid,1993年,3卷,2期,105页
  • 4王川,张祥福,杨发端,卢辉山.nm23基因产物在甲状腺乳头状腺癌中的表达[J].临床与实验病理学杂志,1997,13(1):86-86. 被引量:2
  • 5L. Jayaraman,C. Prives. Covalent and noncovalent modifiers of the p53 protein[J] 1999,Cellular and Molecular Life Sciences(1):76~87

共引文献18

同被引文献8

  • 1戴军,陈方荟,包建东,沈海燕,赵菁,王铁生.桥本甲状腺炎癌变与甲状腺乳头状癌相关性分析[J].诊断病理学杂志,2005,12(6):458-459. 被引量:14
  • 2魏松锋,高明.桥本甲状腺炎并发甲状腺乳头状癌40例临床分析[J].中国实用外科杂志,2006,26(11):862-863. 被引量:26
  • 3郦秀芳,张春丽,张海勇,骆丽青,胡孟钧.桥本甲状腺炎合并甲状腺乳头状癌病理分析[J].浙江临床医学,2007,9(7):996-996. 被引量:4
  • 4[1]Walker RP,Paloyan E.The relationship between Hashimoto's thyroiditis,thyroid neoplasia and peimary hyperparathyroidism[J].Otolaryngol Clinic North Am,1990,23(8):291-295.
  • 5[2]Dipasquale M,Rothstein JL,Palazzo JP.Pathologic features of Hashimoto's-associated papillary thyroid carcinomas[J].Hum Pathol,2001,32(1):24-30.
  • 6[3]Liu LH,Bakhos R,Wojcik EM.Concomitant papillary thyroid carcinoma and Hoshimoto's thyroiditis[J].Semin Diagn Pathol,2001,18(2):99-103.
  • 7[4]Davies TF,Kendler DL.Mechanisms of human autoimmune thyroid disease[J].Monogr Pathol,1993,35:103-117.
  • 8[6]Prasad ML,Huang Y,Pellegata NS,et al.Hashimoto's thyroiditis with papillary thyroid carcinoma(PTC)-like nuclear alterations express molecular markers of PTC[J].Histopathology,2004,45(1):39-46.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部